Stanford University
Showing 5,601-5,700 of 13,128 Results
-
Joel Killen
Professor (Research) of Medicine (General Internal Medicine), Emeritus
Current Research and Scholarly InterestsMy research is focused on the development and evaluation of cigarette smoking prevention and cessation therapies and obesity prevention treatments for children, adolescents and adults.
-
Bora Kim, MD, MAS
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Bora Kim is a board-certified psychiatrist and Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University. With a strong background in neuromodulation, clinical research, and psychiatric epidemiology, Dr. Kim specializes in the treatment of mood disorders, suicidality.
Dr. Kim completed her psychiatry residencies in both South Korea and the United States, providing her with a unique cross-cultural perspective on mental health care in both English and Korean. She holds a Master of Advanced Study (MAS) in Clinical Research from the University of California, San Francisco (UCSF), where she gained expertise in advanced epidemiologic and biostatistical methods. Her clinical expertise includes transcranial magnetic stimulation (TMS) and other neuromodulation techniques for treatment-resistant depression and suicidality.
Dr. Kim’s research focuses on precision psychiatry, with a particular emphasis on the use of repetitive transcranial magnetic stimulation (rTMS) to reduce suicidal ideation. As a faculty member at Stanford, she collaborates with the Brain Stimulation Lab to investigate novel applications of accelerated intermittent theta burst stimulation (aiTBS) in mood disorders and suicidality. -
Cindy Kim
Clinical Rsch Coord 2, Adult Neurology
BioHello, Thank you for connecting with me through my profile. I developed a passion for health and wellness early in life which led me to pursue a B.S. in Health Education with an emphasis in Community Health. My direct patient care experience further solidified my dedication to improving patient outcomes and deepened my understanding of the healthcare system. Driven by my desire to expand my impact, I transitioned into my current role as Clinical Research Coordinator Associate at the Stanford Stroke Center, focusing on advancing the ability to predict stroke risks and improve patient health through the lens of research.
-
Hyunkyung Claire Kim
Postdoctoral Scholar, Endocrinology and Metabolism
BioHyunkyung Claire Kim is a Postdoctoral Research Scholar in the Translational Genomics of Diabetes Lab led by Dr. Anna Gloyn. She received her PhD in Genetics from the University of Chicago, where she developed a statistical method to disentangle shared and trait-specific genetic architecture across complex diseases using large-scale biobank data. Prior to her doctoral training, she worked at Massachusetts General Hospital, studying the genetic subtypes and heterogeneity of type 2 diabetes through data-driven clustering approaches.
She is interested in the translational genomics of diabetes, including integrating human genetics with clinical data to uncover disease mechanisms and advance precision medicine. Her long-term research interests include developing computational methods to understand how genetic, molecular, and environmental factors jointly shape metabolic disease risk, disease heterogeneity, and progression. -
Daniel Kim
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Daniel Kim is a board-certified geriatric psychiatrist who serves as medical director of the inpatient geriatric psychiatry service and program director of the geriatric psychiatry fellowship. His primary area of interest is in the education of medical students, residents, and fellows in geriatric psychiatry.
-
Donghee Kim, MD, PhD
Social Science Research Scholar, Medicine - Med/Gastroenterology and Hepatology
BioI am a physician with specialized training in gastroenterology and hepatology. My research primarily focuses on clinical research into metabolic dysfunction-associated steatotic liver disease (MASLD), chronic liver diseases, and obesity-related gastrointestinal diseases, with a population-based study. In addition, my research has expanded to encompass cardiology, endocrinology, neurology, and psychiatry. I have extensive experience in large epidemiologic cohort studies as well as clinical trials. This work has resulted in over 300 published papers in prominent journals, including Gastroenterology, Journal of Hepatology, Gut, Hepatology, and Clinical Gastroenterology and Hepatology, with the author serving as first or corresponding author. These publications have been cited more than 22000 times with an H-index of 73.
-
Donghoon Kim
Postdoctoral Scholar, Radiology
BioDr. Donghoon Kim is a postdoctoral scholar at Stanford’s Center for Advanced Functional Neuroimaging (CAFN), working in close collaboration with the Stanford Alzheimer’s Disease Research Center (ADRC). His work develops cutting-edge deep learning approaches for multimodal neuroimaging analysis, with an emphasis on the early detection and characterization of Alzheimer’s disease pathology.
Before joining Stanford, he earned his Ph.D. in Biomedical Engineering from the University of California, Davis. His Ph.D. thesis was titled "Deep Learning-Driven Technical Developments and Clinical Applications of Arterial Spin Labeling MRI." During his Ph.D. studies, he focused on the development of advanced deep learning techniques for ASL MRI and its clinical applications. During his master's degree in Biomedical Engineering at Virginia Tech–Wake Forest University, he studied the functional connectivity of the default mode network using resting-state BOLD fMRI among youth football players. -
Edwin Kim
Clinical Assistant Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioDr. Edwin Kim, MD FAPA is an expert and leader in addiction treatment and physician health, who is board-certified in Psychiatry, Addiction Medicine, and Addiction Psychiatry. Dr. Kim is the Director of Addiction Treatment Services at the Veterans Affairs Palo Alto Healthcare System, and a Clinical Assistant Professor (Affiliated) at Stanford University School of Medicine. At the VA Palo Alto, Dr. Kim teaches and supervises medical students, residents and fellows. He is also the President-Elect of the Federation of State Physician Health Programs, and a Councilor-at-Large of the Northern California Psychiatric Society. He currently serves as a Medical Director at the Foundation of the Pennsylvania Medical Society’s Physicians’ Health Program and Nurses’ Health Program.
-
Gloria S. Kim
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsAsian Health
Medical education
Health services delivery
Management of chronic disease
Patient and physician satisfaction -
Grace S. Kim, MD
Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS)
BioGrace S. Kim, MD is a pediatric otolaryngologist and surgeon-scientist in the Department of Otolaryngology–Head & Neck Surgery at Stanford University. Her clinical practice focuses on the full spectrum of pediatric otolaryngology, with particular expertise in hearing loss, chronic ear disease, thyroid disorders, vascular malformations and pediatric head and neck conditions. Her research investigates the immune mechanisms underlying congenital hearing loss and inner ear injury, with the goal of developing therapies to preserve hearing in children.
Dr. Kim received her BA in Biochemical Sciences from Harvard University and her MD from Stanford University School of Medicine, where she also completed an additional year of research as a Howard Hughes Medical Institute Research Fellow. She completed residency training in otolaryngology–head and neck surgery at Stanford, including a two-year NIH-sponsored research fellowship investigating vestibular repair and regeneration, followed by fellowship training in complex pediatric otolaryngology at Stanford.
Dr. Kim joined the Stanford faculty in 2023. She leads a translational research program investigating inner ear neuroimmunology and congenital hearing loss, using animal models to understand how congenital cytomegalovirus infection and immune responses impact the developing auditory system. Her long-term goal is to develop targeted therapies that prevent hearing loss in children. Her work is supported by an NIH Mentored Clinical Scientist Research Career Development (K08) Award, as well as funding from the American Society of Pediatric Otolaryngology and the Stanford Maternal & Child Health Research Institute. -
Hyeonji Kim
Visiting Instructor/Lecturer, Ophthalmology
BioDr. Kim is a translational bioprinting researcher specializing in tissue engineering and ocular regenerative medicine. She holds a Ph.D. in Mechanical Engineering. Her research focuses on developing innovative therapeutic platforms for ocular diseases using 3D bioprinting, biomanufacturing, and regenerative medicine.
She has developed 3D-bioprinted corneal stromal constructs that replicate native collagen alignment and achieve transparency, successfully restoring visual function in preclinical beagle models and subsequent veterinary clinical applications. She also advanced a simplified in situ corneal therapy that has completed veterinary clinical trials and is now licensed for anticipated human trials. Currently, she is developing ocular therapeutic implants using advanced 3D printing approaches.
Dr. Kim has collaborated with regulatory authorities and preclinical evaluation agencies to define guidelines for 3D-printed combination medical devices and to conduct safety testing of bioprinted corneas. Her work has been internationally recognized, contributing to her university's ranking as 12th in Reuters’ 2019 “Top 100 Most Innovative Universities,” and spans drug delivery, diagnostic and therapeutic devices, personalized medicine, and translational ophthalmology. Her long-term vision is to engineer personalized therapeutic implants and biofabrication technologies that bridge fundamental science and clinical translation, initially focusing on restoring vision and ultimately expanding to regenerative therapies for multiple organ systems. -
Jackson Kim, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Kim is a Clinical Assistant Professor in the Division of Nephrology at Stanford Health Care.
Dr. Kim diagnoses and treats a range of conditions affecting the kidneys, including glomerulonephritis, nephrotic syndrome, chronic kidney disease, and genetic kidney disease. He creates a customized, comprehensive treatment plan for every patient he serves.
Dr. Kim has a keen research interest in glomerular kidney disease, particularly glomerulonephritis. He has authored manuscripts, conducted case studies, and published his work in several peer-reviewed journals. -
Jane P. Kim
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Kim’s research focuses on applying statistical approaches to evaluate and improve digital interventions, and using empirical approaches to understand ethical considerations for AI applications in healthcare.
-
Jeewon Sylvia Kim
Program Manager, SPARK at Stanford
Current Role at StanfordProgram manager for SPARK Translational Science Program overseeing educational seminar series, managing projects and facilitating SPARK global operations.
-
Jiyeong Kim
Postdoctoral Scholar, Dermatology
BioDr. Jiyeong Kim is a post-doctoral scholar at the Stanford Center for Digital Health and the Department of Dermatology School of Medicine. As a multi-disciplined data scientist, Dr. Kim applies artificial intelligence (AI) to clinical informatics, harnessing patient-generated health information and data to enhance patient-centered care, which could be tailored to each patient group for improving patient engagement and better health outcomes. In her work, Dr. Kim leverages large language models, machine learning, and natural language processing to understand patients' and caregivers' genuine voices of care needs and needed support for individuals with chronic diseases, not limited to diabetes, cardiovascular disease, and cancer.
Research Interest
-LLMs and Generative AI to Listen to the Patient
-Generative AI-Assisted Enhanced Patient Care
-ML-based Disease Prediction Modeling
-Patient-Generated Data and Precision Health -
Johanna Kim
Executive Director, AIMI, Rad/Integrative Biomedical Imaging Informatics at Stanford
BioJohanna specializes in launching and leading world-class research programs. At Stanford AIMI, she plays a pivotal role in the development and design of all programs, particularly focusing on research and education programs, funding opportunities, and major events. Her leadership extends to shaping partnership programs, fundraising, and enhancing AIMI's outreach strategies. Skilled in building strong teams and fostering interdisciplinary collaborations, Johanna adeptly navigates the complexities of the academic and healthcare sectors. Her strategic support has been invaluable in advancing technology development, securing substantial research funding, and elevating the impact of publications. Johanna’s 20-year career is marked by her commitment to transforming healthcare through innovative technology.
-
Joseph Kim
Clinical Professor, Pediatrics
BioJoseph J. Kim, MD is a Clinical Associate Professor of Pediatrics and Emergency Medicine at the Stanford University School of Medicine. Dr. Kim also serves as the Chief of the Division of Pediatric Hospital Medicine at Stanford University and as the Associate Chief Medical Officer of Stanford Children’s Health. Dr. Kim’s career has focused on medical leadership and program building in pediatric hospital medicine. He has been active locally and nationally promoting patient experience, with particular emphasis on family centered care in pediatric inpatient settings. He has participated in numerous local and national care improvement programs including efforts around bronchiolitis, inpatient asthma management, pediatric sedation, medical co-management of surgical patients and patient care progression in inpatient settings. In his hospital administrative roles he has championed safety rounding, family centered rounding, scheduled based care of inpatients, discharge planning and value based performance improvement. Dr. Kim has mentored dozens of trainees and junior faculty in healthcare leadership and program administration.
Dr. Kim received his BA in Sociology from the University of Virginia and his MD from SUNY Upstate Medical University in Syracuse. He completed his residency in pediatrics at the University of California San Francisco. Clinically, Dr. Kim practices as a Pediatric Hospitalist at Lucile Packard Children’s Hospital Stanford and at California Pacific Medical Center. -
Juliann Lipps Kim
Adjunct Clinical Professor, Pediatrics - General Pediatrics
BioDr. Juliann Kim works as a Pediatric Hospitalist for PAMF. She cares for patients in the LPCH Newborn Nursery, Packard Intermediate Care Nursery, and on the inpatient wards. She serves on several LPCH committees including Professional Performance Evaluation Committee, Perinatal Care Committee, Credentials Committee, and Care Improvement Committee. She served as the LPCH Medical Staff President from 2018-2020.
-
Juyong Brian Kim
Assistant Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsThe lifetime risk of developing cardiovascular disease (CVD) is determined by the genetic makeup and exposure to modifiable risk factors. The Cardiovascular Link to Environmental ActioN (CLEAN) Lab is interested in understanding how various environmental pollutants (eg. tobacco, e-cigarettes, air pollution and wildfire) interact with genes to affect the transcriptome, epigenome, and eventually disease phenotype of CVD. The current focus is to investigate how different toxic exposures can adversely remodel the vascular wall leading to increased cardiac events. We intersect human genomic discoveries with animal models of disease, in-vitro and in-vivo systems of exposure, single-cell sequencing technologies to solve these questions. Additionally, we collaborate with various members of the Stanford community to develop biomarkers that will aid with detection and prognosis of CVD. We are passionate about the need to reduce the environmental effects on health through strong advocacy and outreach.
(http://kimlab.stanford.edu) -
Kaitlyn Kim
Masters Student in Translational Research and Applied Medicine, admitted Autumn 2025
Stanford Student Employee, Health PolicyCurrent Research and Scholarly InterestsCancer Immunotherapy, Solid Tumors, Early-Stage Neurodegeneration, Healthy Aging, Sleep Dysregulation.
-
Kyung Mi Kim
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioKyung Mi Kim, PhD, RN, is a Clinical Assistant Professor at Stanford University, School of Medicine. She has expertise in quantitative methods, including econometrics, large data analysis, and the evaluation of value-based payment policies. She is passionate about care models that lower the cost of high-quality care for frail, older surgical patients and their caregivers, partnering with leaders in health care, science, and technology to achieve the greatest impact.
-
Nathan Geonwoo Kim, MD, MS
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Nathan Geonwoo Kim is a board-certified, fellowship-trained transplant hepatologist with Stanford Health Care. He is also a clinical assistant professor in the Department of Medicine, Division of Gastroenterology & Hepatology at Stanford University School of Medicine.
Dr. Kim specializes in hepatology and liver transplantation (transplant hepatology). He cares for people with severe liver disease, such as cirrhosis, alcohol-associated hepatitis, and metabolic dysfunction-associated steatotic liver disease. Dr. Kim also provides personalized liver cancer care, which may include targeted therapies or liver transplantation to achieve the best possible outcomes.
With a Master of Science in epidemiology and clinical research, Dr. Kim studies hepatocellular carcinoma and outcomes in chronic liver disease. His research focuses on ways to deliver better, more equitable care to people with liver diseases.
Dr. Kim has published his findings in leading medical journals, including the Journal of Hepatology, Clinical Gastroenterology and Hepatology, and Cancer. He has also shared his expertise at national and international conferences, including Digestive Disease Week, The Liver Meeting, and the International Liver Congress. -
Paige Livingston, PA-C
Physician Assistant - Research, Medicine - Med/Blood and Marrow Transplantation
BioPaige has an undergraduate degree in Nutrition from Cal Poly, SLO and completed her Master’s degree in Physician Assistant Studies at Western University of Health Sciences in Southern California before moving to the bay area in November 2016 to join the Stanford Bone Marrow Transplant & Cancer Cell Therapy team. She believes in providing quality care with compassion, taking time to listen to patients and families and helping them navigate complex medical situations and decisions. She has lead the project for APP involvement in Bone Marrow Harvests and serves on the planning committee for a local APP Oncology conference. Her area of clinical practice is bone marrow transplantation and cancer cell therapy.
-
Peter S. Kim
Virginia and D. K. Ludwig Professor of Biochemistry
Current Research and Scholarly InterestsOur research focuses on developing new strategies for vaccine creation. We also aim to generate vaccines targeting infectious agents that have eluded efforts to date. We integrate experimental approaches with protein language models to guide artificial evolution and enable efficient antibody and protein engineering. Our interdisciplinary approach aims to address critical global health challenges.
-
Richard K. Kim
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Richard K. Kim is a board-certified anesthesiologist and Clinical Associate Professor in the Department of Anesthesiology, Perioperative and Pain Medicine. He is fellowship-trained in regional anesthesiology and acute pain medicine (RAAPM), with clinical expertise centered on ultrasound-guided peripheral nerve and truncal/fascial plane blocks, neuraxial techniques, and the perioperative management of acute and complex surgical pain.
As a mentor, he has garnered numerous teaching awards, including the RAAPM Fellowship Teacher of the Year Award. He is actively involved in shaping education for anesthesiology, leveraging evidence-based medicine and clinical informatics to reinforce standards of care while advancing novel approaches to anesthesia.
His scholarly work explores the safety, efficacy, and implementation of regional anesthesia and multimodal analgesia in complex patient care settings, with ongoing work supported by the NIH. This continues to inform consultations and collaborations on questions at the intersection of anesthesia practice, emerging technology, and perioperative pain management.
His administrative work focuses on clinical documentation integrity and the alignment of anesthesia practice with procedural and regulatory standards. -
Samsuk Kim, PhD.
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioDr. Samsuk Kim is a dual research and clinical T32 fellow at Stanford University. She earned her PhD in Clinical Psychology from the University of Detroit Mercy and completed external research training at the University of Michigan (Kratz Lab), where she studied psychosocial factors—such as mindfulness and pain acceptance—in chronic pain. She also completed an APA-accredited internship at the VA Boston Healthcare System. Clinically, Dr. Kim specializes in pain management, health promotion, adjustment-related challenges, and emotional regulation. She draws from a range of evidence-based treatments, including Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), mindfulness-based interventions, Dialectical Behavior Therapy (DBT), and interpersonal psychotherapy. Her current research focuses on understanding the bidirectional relationship between sleep and pain and developing personalized, digital interventions to improve outcomes in both domains.
-
Seung K. Kim M.D., Ph.D.
KM Mulberry Professor, Professor of Developmental Biology, of Medicine (Endocrinology) and, by courtesy, of Pediatrics (Endocrinology)
Current Research and Scholarly InterestsPancreatic islets are essential for human health. We study the development and function of islet cells using modern methods in several model systems, including mice, pigs, human pancreas, primates, embryonic stem cells, and fruit flies. We have discovered critical factors required for islet development and mature islet cell function. These approaches have informed efforts to generate replacement islets, and provide immune protection of transplanted islets for diabetes.
-
Stuart Kim
Professor of Developmental Biology, Emeritus
Current Research and Scholarly InterestsMechanisms of Aging in C. elegans and humans.
-
Sun Kim, M.D. M.S.
Associate Professor of Medicine (Endocrinology)
Current Research and Scholarly InterestsWe are interested in studying the pathophysiological processes that contribute to glucose intolerance and type 2 diabetes mellitus. My current research focuses on characterizing pancreatic beta-cell function in populations with significant insulin resistance and vulnerability to developing diabetes: individuals with schizophrenia, morbid obesity, and history of gestational diabetes.
-
Sunhee S. Kim, MD
Clinical Assistant Professor, Surgery - General Surgery
BioDr. Sunhee Serenity Kim is a board-certified, fellowship-trained general surgeon at Stanford Health Care and clinical assistant professor in the Department of Surgery, Division of General Surgery at Stanford University School of Medicine. She is also the director of emergency general surgery and clinical medical director of the general surgery outpatient clinic at Stanford Health Care Tri-Valley.
Dr. Kim specializes in acute care surgery, applying minimally invasive surgical approaches such as robotic surgery. Dr. Kim treats a broad range of diseases, including gallbladder disease, diverticular disease, ventral and inguinal hernias, and benign breast disease. She has particular interest in enteroatmospheric and enterocutaneous fistula treatment.
Dr. Kim’s research interests have included cytokinesis, rare genetic mutations in blood cancers, and surgical treatment outcomes in people with pancreatic cancer. Most recently, she has performed clinical research with trauma and emergency general surgery patients.
Dr. Kim has published her research in peer-reviewed journals, including The American Journal of Surgical Pathology, Journal of the National Cancer Institute, Nature Communications, and Proceedings of the National Academy of Sciences. She has also presented to her peers at national meetings, including annual meetings of the Society of Surgical Oncology, American Society of Clinical Oncology, and Association for Academy Surgery.
Dr. Kim is a member of the American College of Surgeons (ACS). -
Yeuen Kim
Clinical Associate Professor, Medicine - Vaden Health Center
BioYeuen Kim MD MAS is an internal medicine physician with expertise in population health, medical humanities educational interventions, and working with vulnerable populations in urban settings. She trained at Brown University's Program in Liberal Medical Education and completed residency/chief residency at the Santa Clara Valley Medical Center in San Jose, CA. She has worked with vulnerable populations in ambulatory and mobile settings as a primary care attending and medical outreach physician, as well as completing a Masters' and fellowship in clinical research at UCSF's Department of Biostatistics and Epidemiology & SFGH DGIM, where she evaluated electronic referrals to subspecialty clinics from safety settings (Kim, Chen et al, JGIM 2009.) She worked with the SF and Santa Clara County public health departments to help reduce mortality and improve COVID19 and mpox mitigation, especially at congregate residential facilities through better ventilation, public-private collaboration, and addressing determinants of health for essential workers. Since 2013, she has facilitated art gallery-based workshops for physicians and learners to improve observation and communication skills. She co-leads narrative medicine and oncology workshops for students, residents (Edwards, Kim et al, BMJ Educ 2022) and faculty as a clinical associate professor in Primary care and population health.
-
Yo Sup Kim
Clinical Scholar, Radiology
BioI completed both my diagnostic radiology residency at Indiana University School of Medicine and my MBA at the Kelley School of Business Indiana University on June 2025. I am currently pursuing my fellowship in Musculoskeletal Radiology at Stanford. My healthcare-related interests and research primarily involve applying real world business practices in radiology for optimal efficiency and maximizing value (e.g. using linear regression analysis to finding variables that impact volume of CT studies at the ER). Outside of healthcare, I have entrepreneurial interests particularly in the area of venture capitalism for tech and service companies. Prior to medical school, I ran my family's floral bouquet company in California.
-
Yong Yean Kim
Assistant Professor of Pediatrics ( Hematology & Oncology)
BioOur lab is interested in translational science to bring new therapies to clinical trials. In particular, we are interested in pediatric sarcomas which have not had advancement in clinical treatment for decades. Current projects in the lab focus on understanding of the biology of fusion transcription factor PAX3::FOXO1 which is the driver mutation in fusion positive rhabdomyosarcoma. PAX3::FOXO1 is a powerful oncogenic transcription factor which rewires the transcriptional organization to lock the cancer cell in the proliferative state. Since transcription factors including PAX3::FOXO1 are difficult to target using small molecules, we aim to understand how PAX3::FOXO1 is regulated and targeting the regulators of PAX3::FOXO1. By understanding and targeting the regulation of PAX3::FOXO1, we hope to bring new therapies for fusion positive rhabdomyosarcoma. Additionally, these regulatory mechanisms may also be active in other transcription driven cancers such as the EWSR1::FLI1 driven Ewings Sarcoma.
Our lab is also interested in exploring the epigenetic landscape of pediatric solid tumors and trying to understand how dysregulation in the epigenome drives oncogenesis. We utilize various CRISPR mediated genetic techniques to interrogate the regulators of epigenome focusing on the histone lysine demethylases (KDMs). KDMs are an understudied group of epigenetic regulators which can be targeted for therapeutic effect. We explore the role of KDMs in pediatric solid tumors and hope to identify potential targets for drug development.
